Zhiwu Jiang

Guangxi University — China

Immunology and Microbiology · Life Sciences

21h-index1.8kcitations69works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(15), CAR-T cell therapy research(14), Acute Lymphoblastic Leukemia research(9), Virus-based gene therapy research(7), Acute Myeloid Leukemia Research(6)

Publications69 total

A lightweight citrus detection and counting method based on deep learning model
Engineering Applications of Artificial Intelligence·2025
RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53 <sup>R249S</sup> Mutation and is a Potential Therapeutic Target
Advanced Science·2025Open Access
Research on efficient and fast extraction of vineyard navigation path based on key point detection
Engineering Applications of Artificial Intelligence·2025
T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity
Cell Reports·2025Open Access
Detection and picking point localization of grape bunches and stems based on oriented bounding box
Computers and Electronics in Agriculture·2025· 16 cited
Knowledge-Guided Neural Network based Nonlinear Current Model with Combined Loss Function
2024
<scp>BCL11B</scp> and the <scp>NuRD</scp> complex cooperatively guard T‐cell fate and inhibit <scp>OPA1</scp> ‐mediated mitochondrial fusion in T cells
The EMBO Journal·2023· 17 citedOpen Access
T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity
Cell Reports·2023· 12 citedOpen Access
Investigation of the Performance of Heterogeneous MOF-Silver Nanocube Nanocomposites as CO<sub>2</sub> Reduction Photocatalysts by In Situ Raman Spectroscopy
ACS Applied Materials & Interfaces·2023· 33 cited
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
Nature Communications·2022· 40 citedOpen Access
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D
Molecular Therapy — Oncolytics·2022· 16 citedOpen Access
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies
Frontiers in Immunology·2022· 13 citedOpen Access
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors
EMBO Reports·2022· 13 citedOpen Access
Human induced-T-to-natural killer cells have potent anti-tumour activities
Biomarker Research·2022· 18 citedOpen Access
Additional file 3 of Human induced-T-to-natural killer cells have potent anti-tumour activities
Figshare·2022Open Access
Additional file 9 of Human induced-T-to-natural killer cells have potent anti-tumour activities
Figshare·2022Open Access
Additional file 2 of Human induced-T-to-natural killer cells have potent anti-tumour activities
Figshare·2022Open Access
Additional file 1 of Human induced-T-to-natural killer cells have potent anti-tumour activities
Figshare·2022Open Access
Additional file 8 of Human induced-T-to-natural killer cells have potent anti-tumour activities
Figshare·2022Open Access
In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers
Genome Medicine·2021· 20 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Peng Li(38), Yao Yao(20), Pentao Liu(16), Duanqing Pei(13), Yangqiu Li(13), Bing Xu(12), Qiting Wu(11), Xin Du(11), Le Qin(11), Manman Deng(11), Jianyu Weng(10), Zhaoyang Tang(10), Peilong Lai(9), Xinru Wei(8), Youguo Long(8), Simiao Lin(7), Ruocong Zhao(7), Baiheng Li(6), Zhenfeng Zhang(6), Suna Wang(6)